封面
市場調查報告書
商品編碼
1488636

病患參與解決方案市場:依組件類型、依交付類型、依治療領域、依應用、依最終用戶、依地區、機會、預測,2017-2031 年

Patient Engagement Solutions Market Assessment, By Component Type, By Delivery Type, By Therapeutic Area, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日期: | 出版商: Market Xcel - Markets and Data | 英文 223 Pages | 商品交期: 3-5個工作天內

價格

2024-2031 年預測期間,全球患者參與解決方案市場規模將以 15.09% 的複合年增長率增長,從 2023 年的 230.2 億美元增長到 2031 年的 708.8 億美元。患者參與解決方案涉及許多技術和平台,旨在改善患者體驗、與醫療保健提供者溝通以及其他有助於成功醫療保健服務的事物。預計患者參與解決方案市場在未來幾年將顯著擴大。有幾個因素可能會擴大市場,包括人口老化、技術進步、慢性病盛行率的增加以及人口整體健康意識的提高。

此外,業界正在推出更小、更智慧的設備,這些設備不僅有助於早期發現任何疾病,而且還可以提供更快、更準確的醫療結果。隨著人們越來越意識到健康生活方式的好處,它變得越來越流行。領先的市場參與者和醫療保健參與者正在合作,為患者提供最好的工具和診斷解決方案。公共和商業組織都在籌集資金並大力投資以提供高品質的解決方案。這些巨頭公司在開發和推出新產品時採用聯盟、投資、併購等策略手段。

本報告調查了全球患者參與解決方案市場,依組件類型、交付類型、治療領域、應用、最終用戶、地區和市場參與者提供了市場概況,並提供了公司概況。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第 4 章 2017-2031 年全球病患參與解決方案市場展望

  • 市場規模與預測
  • 依組件類型
  • 依交付類型
  • 依治療領域
  • 依用途
  • 依最終用戶
  • 依地區
  • 各公司的市佔率 (%),2023 年

第 5 章全球病患參與解決方案市場展望(依地區劃分,2017-2031 年)

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第 6 章 2023 年市場規劃

第七章宏觀環境與產業結構

  • 需求與供給分析
  • 匯入/匯出分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

第 9 章監理架構與創新

第十章主要參會企業狀況

第11章價格分析

第 12 章案例研究

第 13 章主要進入者展望

  • McKesson Corporation
  • Oracle Corporation
  • Veradigm LLC
  • Athenahealth, Inc.
  • Orion Health
  • Epic Systems Corporation
  • Harris Healthcare
  • Lincor Inc.
  • AdvanceMed Corporation
  • Oneview Healthcare PLC

第 14 章策略建議

第十五章查詢及免責聲明

Product Code: MX11425

Global patient engagement solutions market is projected to witness a CAGR of 15.09% during the forecast period 2024-2031F, growing from USD 23.02 billion in 2023 to USD 70.88 billion in 2031F. Patient engagement solutions involve a landscape of many technologies and platforms which aim towards the betterment of patient-experience, provider communication, and all such things that lead to the success of healthcare services. The market for patient engagement solutions is anticipated to expand significantly in the coming years. The market has the potential to expand due to several factors, including ageing population, technology advancements, increased prevalence of chronic disorders, and an overall increasing population that is aware of its own health.

Additionally, the industry has seen the launch of compact and smart devices that provide faster and more precise medical findings in addition to being helpful in the early detection of any disorders. A healthy lifestyle is getting more popular as people become more conscious about its benefits. Big market players and healthcare practitioners are collaborating to provide the best tools and diagnostic solutions for patients. Both public and commercial organizations are raising money and investing a sizable sum of it to be able to provide quality solutions. These massive corporations use strategic maneuvers such as collaborations, investments, and mergers and acquisitions when they are striving to develop or introduce a new product.

For instance, healthcare providers can utilize Zocdoc Practice Solutions, which was introduced by Zocdoc in September 2023. It is a free, user-friendly toolkit designed to make it easier for clinicians to reach, manage, and retain patients. It comprises of services such as online appointment booking for a website, receiving insurance cards, identification, paperwork, and much more. Similarly, research on the effectiveness of using Upfront Healthcare's patient engagement platform for orthopedic total joint care cases, including hip and knee replacements, was released in February 2024 by Riverside Doctors' Hospital.

Increasing Prevalence of Chronic Diseases to Gain Market Share

Globally, the prevalence of chronic diseases has increased significantly in recent years, posing a serious challenge to healthcare systems everywhere. There is an increasing demand for novel approaches to facilitate patient care and management as the prevalence of chronic ailments, including diabetes, cardiovascular diseases, and respiratory problems, keeps rising. As a result, there is a noticeable upsurge in the global market for patient engagement solutions, driven by the urgent need to improve patient outcomes and simplify healthcare delivery.

Globally, chronic diseases have emerged as a major source of morbidity and mortality due to their protracted duration and sluggish progression. Conditions are becoming more common due to several factors, including ageing population, poor lifestyle, and inadequate access to preventive healthcare. For instance, a report published by NIH in January 2023, stated that in the United States, the number of people who are above the age of 50 will increase from 137.25 million in 2020 to 221.13 million in 2050 which is an increase of 61.11%. Out of this population, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050.

Consequently, there is increasing demand on healthcare professionals to devise efficient strategies for handling chronic illnesses and guaranteeing patients taking an active role in their own treatment. Preventative treatment's role in managing chronic illnesses is becoming more widely acknowledged by healthcare systems. To reduce the impact of chronic illnesses, patient engagement solutions are essential in promoting healthy behaviors, encouraging routine screenings, and offering early intervention. Patient engagement technologies enable people to participate in their own health management actively. Patients who have access to features such as medication reminders, individualized health records, and lifestyle management tools are more likely to be interested and knowledgeable about their condition and to follow their treatment regimens. Through a variety of programs and incentives, governments and regulatory agencies around the globe are encouraging the implementation of patient engagement technologies. These measures aim to improve healthcare outcomes, reduce healthcare costs, and enhance the overall efficiency of healthcare systems.

Technological Advancements in the Market

Patient involvement has become increasingly important in the ever-changing healthcare landscape when it comes to improving overall patient satisfaction and healthcare outcomes. The world is seeing an unprecedented amount of growth in the patient engagement solutions market due to the rapid advancements in technology. The introduction of innovative technologies has caused a substantial change in the healthcare industry.

Patient engagement solutions are no different, utilizing big data analytics, the Internet of Things (IoT), and artificial intelligence (AI) to deliver individualized and effective healthcare experiences. Predictive analytics, remote monitoring tools, and chatbots powered by Al are enabling patients to take charge of their own health by easily communicating with healthcare professionals. The emergence of remote patient monitoring (RPM) is one of the significant technical developments propelling the market of patient engagement solutions. Patients can monitor vital signs, medication, and lifestyle factors from the comfort of their homes with wearable devices that have sensors built in them. Personalized treatment plans and prompt interventions are made possible by the transmission of this real-time data to healthcare practitioners.

In addition to improving patient participation, RPM lowers healthcare expenses and hospital admissions by supporting preventive healthcare. The widespread use of smartphones has made it possible for mobile health applications, which are essential for patient involvement. Instant access to health information, appointment scheduling, prescription reminders, and safe communication with healthcare practitioners are made possible by these applications for users. Due to developments in Big Data analytics, healthcare professionals may now examine enormous volumes of patient data to identify trends and patterns in each patient's health. Following that, treatment programs and interventions are customized based on the unique requirements of each patient.

By enabling virtual consultations, video conferencing, and secure messaging, interactive patient portals and telehealth technologies further improve the patient experience by removing geographical constraints and guaranteeing ongoing interaction. Maintaining the trust of patients and healthcare providers requires striking a balance between security and innovation. The market for patient engagement solutions is expanding significantly on a global scale as healthcare providers realize how important technology is for the betterment of patient outcomes.

For instance, EPIC, an EHR vendor, launched CHEERS in March 2022, its first-ever customer-relationship management technology for healthcare systems. Ever since COVID-19, customers have requested that manufacturers come up with an improved version of this system that will better facilitate their communication with professionals.

Increasing Demand for Web and Cloud-Based Platforms

Delivery options, which are web and cloud-based, are becoming the mainstay of patient engagement programs. These distribution systems are perfect for contemporary healthcare environments since they are scalable, accessible, and provide real-time connectivity. Web and cloud-based platforms, in contrast to conventional on-premises solutions, offer a smooth and safe means of communication, information sharing, and remote health metrics monitoring for patients and healthcare practitioners. Geographical boundaries can be eliminated due to web and cloud-based patient engagement systems, which let patients access healthcare services from the comfort of their homes.

Better adherence to treatment programs and better healthcare outcomes, encourages patients to become more involved and engaged in their healthcare journey. Real-time data exchange between patients and healthcare professionals is made easier with cloud-based delivery. The rapid information interchange facilitates prompt decision-making, customized treatment strategies, and timely- interventions. Patient care consequently becomes more dynamic and individualized. Cloud-based solutions' scalability guarantees that healthcare providers can adjust to shifting patient loads and changing technology environments. Pay-as-you-go cloud computing models provide cost efficiencies, allowing these solutions to be beneficial to a wider range of healthcare organizations of all sizes.

Interoperability is frequently given top priority in web and cloud-based patient interaction solutions, enabling smooth integration with current electronic health records (EHRs) and other healthcare systems. Improved information exchange throughout the healthcare continuum because of interoperability results in more comprehensive and well-coordinated patient treatment. For instance, the debut of Philips Virtual Care Management, a comprehensive portfolio of flexible solutions and services to help health systems, providers, payers, and employer groups more deeply connect and motivate patients from virtually anywhere, was announced recently in 2023 by Philips, a global leader in healthcare technology. By lowering ER visits and improving chronic illness management, Philips virtual care management can lower healthcare costs and alleviate the burden on hospital employees.

North America to Dominate the Patient Engagement Solutions Market

The market is anticipated to be dominated by North America. With a greater population and hence a heavier burden of patients in hospitals, North America is predicted to hold a sizable market share in the patient management solutions industry. There are approximately 6,120 hospitals that are currently in operation in the United States, according to data released by the American Hospital Association (AHA) in 2022. By 2060, there will be 95 million Americans 65 and older, according to PRB Ageing in the United States. With the rising prevalence of chronic disorders in the population, engagement of population with healthcare services is increasing significantly. The lifestyle of people is one of the major factors behind the rise in chronic diseases in the region.

North America being one of the top-most regions in terms of technology and advanced tools used by people in their daily lives, it is the most progressive region that can adopt newer patient engagement solutions faster than others. Over the projection period, new product introductions will support the growth of the segment. Such regional development is anticipated to accelerate market expansion. Therefore, the examined market in North America is anticipated to show development throughout the forecast period due to the above-mentioned aspects.

Future Market Scenario (2024 - 2031F)

One of the main factors contributing to the anticipated growth of the patient engagement solutions market is the increasing population which will continue to grow in future, and awareness about being health conscious. Given that technology is advancing, we can expect innovative technology in the area. Players in the market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, DeliverHealth initiated its partner programme in March of 2022. Through the DeliverHealth program, strategic partners in the healthcare ecosystem are supported, sales are increased both locally and abroad, and healthcare organizations can lower overall costs, improve patient outcomes, and simplify the daily difficulties of healthcare.

Key Players Landscape and Outlook

Several companies are expanding their business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed patient engagement solutions to help researchers and to bring up their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways in which they are trying to achieve the same.

Greenway Health and Ambient AI Assistant Nabla partnered in April 2024 to integrate the latter's innovative AI technology into Greenway's EHR solutions. It allows clinicians to save up to two hours a day by utilizing AI-powered clinical documentation, which reduces administrative burdens and improves patient engagement by freeing providers to concentrate on high-quality care.

Matrix Medical Network and Linkwell Health partnered in April 2024 to take advantage of Linkwell's omnichannel engagement platform and patient activation expertise to improve patient experience, increase patient utilization of Matrix's services, and enable people to get better health outcomes by meeting them where they live.

Table of Contents

1.Research Methodology

2.Project Scope and Definitions

3.Executive Summary

4.Global Patient Engagement Solutions Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
  • 4.2.By Component Type
    • 4.2.1.Hardware
    • 4.2.2.Software
    • 4.2.3.Services
  • 4.3.By Delivery Type
    • 4.3.1.On-Premises
    • 4.3.2.Web/Cloud Based
  • 4.4.By Therapeutic Area
    • 4.4.1.Health and Wellness
    • 4.4.2.Chronic Disease Management
    • 4.4.3.Others
  • 4.5.By Application
    • 4.5.1.Healthcare Management
    • 4.5.2.Home Healthcare Management
    • 4.5.3.Social and Behavioral Management
    • 4.5.4.Financial Health Management
  • 4.6.By End-user
    • 4.6.1.Payers
    • 4.6.2.Providers
    • 4.6.3.Patients
  • 4.7.By Region
    • 4.7.1.North America
    • 4.7.2.Europe
    • 4.7.3.Asia-Pacific
    • 4.7.4.South End-user America
    • 4.7.5.Middle East and Africa
  • 4.8.By Company Market Share (%), 2023

5.Global Patient Engagement Solutions Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
    • 5.1.2.By Component Type
      • 5.1.2.1.Hardware
      • 5.1.2.2.Software
      • 5.1.2.3.Services
    • 5.1.3.By Delivery Type
      • 5.1.3.1.On-Premises
      • 5.1.3.2.Web/Cloud Based
    • 5.1.4.By Therapeutic Area
      • 5.1.4.1.Health and Wellness
      • 5.1.4.2.Chronic Disease Management
      • 5.1.4.3.Others
    • 5.1.5.By Application
      • 5.1.5.1.Healthcare Management
      • 5.1.5.2.Home Healthcare Management
      • 5.1.5.3.Social and Behavioral Management
      • 5.1.5.4.Financial Health Management
    • 5.1.6.By End-user
      • 5.1.6.1.Payers
      • 5.1.6.2.Providers
      • 5.1.6.3.Patients
    • 5.1.7.United States*
      • 5.1.7.1.Market Size & Forecast
        • 5.1.7.1.1.By Value
      • 5.1.7.2.By Component Type
        • 5.1.7.2.1.Hardware
        • 5.1.7.2.2.Software
        • 5.1.7.2.3.Services
      • 5.1.7.3.By Delivery Type
        • 5.1.7.3.1.On-Premises
        • 5.1.7.3.2.Web/Cloud Based
      • 5.1.7.4.By Therapeutic Area
        • 5.1.7.4.1.Health and Wellness
        • 5.1.7.4.2.Chronic Disease Management
        • 5.1.7.4.3.Others
      • 5.1.7.5.By Application
        • 5.1.7.5.1.Healthcare Management
        • 5.1.7.5.2.Home Healthcare Management
        • 5.1.7.5.3.Social and Behavioral Management
        • 5.1.7.5.4.Financial Health Management
      • 5.1.7.6.By End-user
        • 5.1.7.6.1.Payers
        • 5.1.7.6.2.Providers
        • 5.1.7.6.3.Patients
    • 5.1.8.Canada
    • 5.1.9.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Component Type
  • 6.2.By Delivery Type
  • 6.3.By Therapeutic Area
  • 6.4.By Application
  • 6.5.By End-user
  • 6.6.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.McKesson Corporation
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Oracle Corporation
  • 13.3.Veradigm LLC
  • 13.4.Athenahealth, Inc.
  • 13.5.Orion Health
  • 13.6.Epic Systems Corporation
  • 13.7.Harris Healthcare
  • 13.8.Lincor Inc.
  • 13.9.AdvanceMed Corporation
  • 13.10.Oneview Healthcare PLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 3.Global Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 4.Global Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 5.Global Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 6.Global Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Patient Engagement Solutions Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 10.North America Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 11.North America Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 12.North America Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 13.North America Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Patient Engagement Solutions Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 17.United States Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 18.United States Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 19.United States Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 20.United States Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 23.Canada Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 24.Canada Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 25.Canada Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 26.Canada Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 29.Mexico Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 30.Mexico Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 31.Mexico Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 32.Mexico Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 35.Europe Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 36.Europe Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 37.Europe Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 38.Europe Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Patient Engagement Solutions Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 42.Germany Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 43.Germany Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 44.Germany Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 45.Germany Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 48.France Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 49.France Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 50.France Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 51.France Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 54.Italy Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 55.Italy Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 56.Italy Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 57.Italy Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 60.United Kingdom Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 61.United Kingdom Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 62.United Kingdom Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 63.United Kingdom Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 66.Russia Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 67.Russia Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 68.Russia Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 69.Russia Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 72.Netherlands Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 73.Netherlands Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 74.Netherlands Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 75.Netherlands Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 78.Spain Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 79.Spain Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 80.Spain Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 81.Spain Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 84.Turkey Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 85.Turkey Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 86.Turkey Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 87.Turkey Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 90.Poland Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 91.Poland Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 92.Poland Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 93.Poland Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 96.South America Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 97.South America Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 98.South America Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 99.South America Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Patient Engagement Solutions Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 103.Brazil Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 104.Brazil Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 105.Brazil Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 106.Brazil Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 109.Argentina Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 110.Argentina Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 111.Argentina Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 112.Argentina Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 115.Asia-Pacific Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 116.Asia-Pacific Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 117.Asia-Pacific Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 118.Asia-Pacific Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Patient Engagement Solutions Market Share (%), By Country, 2017-2031F
  • Figure 120.India Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 122.India Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 123.India Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 124.India Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 125.India Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 128.China Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 129.China Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 130.China Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 131.China Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 134.Japan Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 135.Japan Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 136.Japan Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 137.Japan Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 140.Australia Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 141.Australia Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 142.Australia Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 143.Australia Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 146.Vietnam Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 147.Vietnam Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 148.Vietnam Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 149.Vietnam Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 152.South Korea Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 153.South Korea Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 154.South Korea Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 155.South Korea Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 158.Indonesia Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 159.Indonesia Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 160.Indonesia Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 161.Indonesia Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 164.Philippines Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 165.Philippines Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 166.Philippines Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 167.Philippines Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 170.Middle East & Africa Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 171.Middle East & Africa Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 172.Middle East & Africa Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 173.Middle East & Africa Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Patient Engagement Solutions Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 177.Saudi Arabia Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 178.Saudi Arabia Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 179.Saudi Arabia Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 180.Saudi Arabia Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 183.UAE Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 184.UAE Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 185.UAE Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 186.UAE Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Patient Engagement Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Patient Engagement Solutions Market Share (%), By Component Type, 2017-2031F
  • Figure 189.South Africa Patient Engagement Solutions Market Share (%), By Delivery Type, 2017-2031F
  • Figure 190.South Africa Patient Engagement Solutions Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 191.South Africa Patient Engagement Solutions Market Share (%), By Application, 2017-2031F
  • Figure 192.South Africa Patient Engagement Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Component Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Delivery Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Therapeutic Area Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 198.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023